ADM Stock - Archer-Daniels-Midland Company

Archer-Daniels-Midland (ADM) has undergone a significant period of institutional restructuring and financial restatement following the discovery of material weaknesses in its internal control over financial reporting (ICFR). These weaknesses primarily concerned the pricing and reporting of intersegment sales between the Nutrition segment and other business units.

Executive Overview: Guidance Revision & Control Failures

In late 2024, ADM revised its full-year 2024 adjusted earnings per share (EPS) guidance downward to a range of $4.50 to $5.00, reflecting both market headwinds and internal operational challenges. This followed an internal investigation that revealed historical overstatements of the Nutrition segment's operating profit—by as much as 10% in certain fiscal years—due to intersegment transactions that were not recorded at market-equivalent prices.

Specific Remediation Steps

Management has implemented a multi-faceted remediation plan designed to address the "root causes" of these control failures:

• Leadership Overhaul: The appointment of Monish Patolawala (former 3M CFO) as EVP and CFO in August 2024 was a pivotal step in restoring institutional credibility. Patolawala has prioritized "operating rigor" and the enhancement of governance and controllership compliance.
• Enhanced Control Framework: ADM implemented new controls specifically targeting the measurement and application of accounting guidance for intersegment sales. This includes a more transparent valuation process to ensure all internal transfers approximate market pricing.
• Financial Restatements: The company amended its FY2023 Form 10-K and Q1/Q2 2024 Form 10-Qs to correct misclassified intersegment and intrasegment transactions. These restatements were necessary to decouple the Nutrition segment’s performance from artificial "flattery" provided by other segments.
• Operational Simplification: To reduce reporting complexity, management downsized the Nutrition unit by slashing two-thirds of its brands and reducing product offerings by 17%. Additionally, more than 20 production lines in the animal nutrition subsegment were decommissioned.
• Personnel Training & ERP Integration: ADM increased training for relevant accounting personnel and continued the phased rollout of a global Enterprise Resource Planning (ERP) system to standardize data integrity across its 18+ legal entities.

Impact on Reporting Integrity (2025 Outlook)

The remediation efforts reached a critical milestone in mid-2025, with management declaring the material weakness officially remediated as of the Q2 2025 reporting period.

• Restored Transparency: Moving into 2025, the Nutrition segment's reporting integrity is supported by a "market-based" pricing model for internal sales, eliminating the profit-shifting practices that previously inflated margins.
• Segment Realignment: The restructuring has led to a more "simplified" portfolio, which management believes will improve the predictability of the Nutrition segment's results. By Q3 2025, the segment reported an operating profit of $130M, a 24% year-over-year increase, signaling that the new controls have not hindered operational recovery.
• Guidance Volatility: Despite improved reporting integrity, ADM further revised its 2025 full-year adjusted EPS guidance in late 2025 to $3.25 - $3.50 (down from an initial ~$4.00). This revision was attributed to external market factors, such as lower crush margins, rather than further accounting adjustments.

Risks and Regulatory Oversight

While the material weakness has been remediated, ADM remains under the scrutiny of the Securities and Exchange Commission (SEC) and the Department of Justice (DOJ). The SEC recently settled charges against ADM and two former executives, emphasizing that the company's narrative of double-digit growth in Nutrition was historically "propped up" by improper adjustments. Future reporting integrity will depend on the sustained effectiveness of the new CFO’s governance framework and the successful completion of the global ERP transition.

The current compression in soybean crush margins and the cyclical glut in global grain markets necessitate a fundamental recalibration of Archer-Daniels-Midland’s (ADM) valuation. As the Ag Services and Oilseeds (AS&O) segment—which historically contributes approximately 70-80% of operating profit—navigates a "commodity down cycle," investors must shift from peak-cycle earnings multiples to a normalized "mid-cycle" or "trough-cycle" framework.

1. Segmental Headwinds and Margin Compression

The AS&O segment is facing a "perfect storm" of oversupply and regulatory uncertainty. Global soybean crush margins have collapsed from record highs in 2022-2023 to levels significantly below historical averages.

• Crushing Sub-segment: Operating profit in this sub-segment fell by -85% YoY in recent quarters, driven by a surge in industry capacity and competitive Argentine meal exports. Executed soy crush margins have been approximately $13/ton lower YoY, while canola margins have seen a sharper compression of $40/ton.
• Ag Services Sub-segment: This unit has seen a -31% to -53% decline in operating profit due to slower farmer selling and higher logistics costs. The stabilization of global trade flows has also reduced the "volatility capture" opportunities that ADM leveraged during the 2022 supply shocks.

2. Global Grain Market Oversupply through H1 2025

The risk of sustained oversupply is anchored by record production forecasts in South America. Brazil is anticipating a record soybean crop of 177.6M tons for the 2025/2026 season, while Argentina’s recovery further saturates the global market.

• Inventory Glut: Global grain ending stocks for 2025/26 are projected to reach a record 586M tons. This "era of abundance" keeps the basis (the difference between local cash prices and futures) weak, limiting ADM’s origination margins.
• Biofuel Policy Lag: The delay in U.S. Treasury guidance on the 45Z Clean Fuel Production Credit and uncertainty regarding Renewable Volume Obligations (RVO) have dampened demand for soybean oil, a key feedstock. Without policy clarity, ADM faces an estimated $0.50 EPS headwind in 2025.

3. Valuation Recalibration Framework

To account for these risks, valuation should be adjusted using a Normalized Earnings Power approach rather than trailing metrics, which are currently distorted by the earnings slump.

• P/E Multiple Normalization: ADM’s 10-year average P/E ratio is approximately 15.1x. While the trailing P/E has spiked to 27x-30x due to the -50% decline in YTD net earnings, a recalibrated valuation should apply a 12x-14x multiple to a "mid-cycle" EPS of $4.00-$4.50.
• Guidance Revision: Management has already lowered 2025 adjusted EPS guidance to a range of $3.25–$3.50. Investors should treat the lower end of this range as the "trough" baseline for H1 2025.
• Cost of Capital Adjustments: Given the increased regulatory and trade-policy volatility, a slight upward adjustment to the Weighted Average Cost of Capital (WACC)—currently estimated around 7.6%—may be appropriate to reflect the higher risk premium of the AS&O segment.

4. Mitigation and "Self-Help" Catalysts

ADM is attempting to floor its valuation through aggressive internal actions and segment diversification:

• Cost Optimization: A targeted workforce reduction of 700 jobs and a multi-year cost-saving goal of $500M-$750M.
• Nutrition Recovery: The Nutrition segment, though smaller, showed a +13% to +24% profit improvement in recent periods, providing a partial hedge against the commodity-driven AS&O decline.
• Capital Allocation: ADM returned $3.1B to shareholders in 2024 via dividends and $2.3B in buybacks, supporting the stock price despite fundamental weakness.

5. Summary of Risks and Uncertainties

The primary risk to this recalibration is a further deterioration in U.S.-China trade relations, which could lead to a total suspension of U.S. soybean purchases, as seen in previous cycles. Conversely, an earlier-than-expected finalization of the 45Z tax credit could serve as a major catalyst for a margin rebound in H2 2025.

The resolution of the long-standing investigations by the Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) in early 2026 marks a pivotal transition for Archer-Daniels-Midland (ADM). While the investigations into intersegment pricing practices within the Nutrition segment created significant governance overhang throughout 2024 and 2025, the recent settlements provide a clearer framework for the company’s capital allocation strategy in the current fiscal year.

🏛️ Investigation Resolution and Governance Context

On January 27, 2026, ADM reached a settlement with the SEC, agreeing to a civil penalty of $40M to resolve allegations of materially inflating the performance of its Nutrition segment through non-market intersegment sales. Crucially, the DOJ closed its parallel investigation with no further action against the company.

While the SEC continues to litigate against former CFO Vikram Luthar, the company itself has remediated the "material weakness" in its internal controls as of late 2025. From a capital allocation perspective, the most significant finding was that the accounting adjustments—while distorting segment-level reporting—had no impact on ADM’s consolidated balance sheets, net earnings, or cash flows. This "consolidated neutrality" is the fundamental pillar supporting the company's current payout and repurchase capabilities.

💰 Dividend Growth Sustainability

ADM’s status as a "Dividend Aristocrat" remains a core component of its value proposition. In February 2026, the Board of Directors signaled continued confidence by declaring a quarterly dividend of $0.52 per share, marking the 53rd consecutive year of dividend increases.

• Cash Flow Coverage: Despite a -39% contraction in GAAP net earnings for FY 2025 (totaling $1.1B), ADM’s cash flow from operations remains robust. For the first nine months of 2025, the company generated $5.8B in operating cash flow.
• Payout Ratio: The current dividend level represents a disciplined portion of the projected 2026 adjusted EPS range of $3.60 - $4.25.
• Sustainability Outlook: Because the intersegment pricing issues did not involve "phantom" cash, the dividend's sustainability is tied more to global "crush margins" and commodity cycles than to the regulatory settlement. The $40M penalty is negligible relative to ADM's $32.7B market capitalization.

🔄 Share Repurchase Program Pace

The pace of ADM’s multi-billion dollar share repurchase program is expected to remain aggressive in 2026, serving as both a signal of management confidence and a mechanism to support EPS growth amidst margin volatility.

• Program Extension: ADM recently extended its share repurchase authorization through 2029. As of early 2026, the company has approximately 114.8M shares remaining under its current authorization.
• Strategic Intent: Management has utilized the "valuation dip" caused by the investigation to accelerate buybacks, reducing the total share count by approximately 14% over the last five years.
• 2026 Execution: With the DOJ investigation closed, the "legal cloud" that often restricts the timing of buybacks (due to possession of material non-public information) has largely dissipated. This allows for more tactical execution of the $2B program announced in 2024, particularly if the stock continues to trade at a discount to its historical forward P/E multiples.

⚠️ Risks and Forward-Looking Considerations

While the regulatory resolution is a tailwind for capital allocation certainty, several diagnostic risks remain:

1. Operational Recovery in Nutrition: The Nutrition segment's operating profit fell -11% in Q4 2025. If the segment fails to return to its projected 15% - 20% growth trajectory, the company may face pressure to pivot capital away from buybacks toward M&A or internal restructuring.
2. Macroeconomic Volatility: ADM’s 2026 guidance assumes a recovery in soy crush margins and biofuel policy clarity. A failure in these market fundamentals would constrain the free cash flow available for the "discretionary" portion of the buyback program.
3. Cost-Saving Targets: The company has initiated a program to deliver $500M - $750M in cost savings by 2029. The successful execution of this plan is critical to maintaining the current pace of capital returns if revenue growth remains stagnant.